MX20055A - Procedimiento para la preparacion de una composicion acuosa de ibuprofen y procedimiento para su preparacion. - Google Patents

Procedimiento para la preparacion de una composicion acuosa de ibuprofen y procedimiento para su preparacion.

Info

Publication number
MX20055A
MX20055A MX2005590A MX2005590A MX20055A MX 20055 A MX20055 A MX 20055A MX 2005590 A MX2005590 A MX 2005590A MX 2005590 A MX2005590 A MX 2005590A MX 20055 A MX20055 A MX 20055A
Authority
MX
Mexico
Prior art keywords
procedure
preparation
ibuprofen
aqueous composition
aqueous
Prior art date
Application number
MX2005590A
Other languages
English (en)
Other versions
MX173433B (es
Inventor
Solomon Motola
Annabelle Mogavero
Gary R Agisim
Pamela N Panopoulos
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of MX20055A publication Critical patent/MX20055A/es
Publication of MX173433B publication Critical patent/MX173433B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MX020055A 1989-03-28 1990-03-27 Composicion acuosa de ibuprofen y procedimiento para su preparacion MX173433B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/329,624 US4975465A (en) 1989-03-28 1989-03-28 Orally administrable ibuprofen compositions

Publications (2)

Publication Number Publication Date
MX20055A true MX20055A (es) 1993-10-01
MX173433B MX173433B (es) 1994-03-03

Family

ID=23286273

Family Applications (1)

Application Number Title Priority Date Filing Date
MX020055A MX173433B (es) 1989-03-28 1990-03-27 Composicion acuosa de ibuprofen y procedimiento para su preparacion

Country Status (15)

Country Link
US (1) US4975465A (es)
EP (1) EP0390369B1 (es)
JP (1) JP2847134B2 (es)
KR (1) KR0143899B1 (es)
AR (1) AR245366A1 (es)
AT (1) ATE100313T1 (es)
AU (1) AU629622B2 (es)
CA (1) CA1336819C (es)
DE (1) DE69006068T2 (es)
DK (1) DK0390369T3 (es)
ES (1) ES2048428T3 (es)
HK (1) HK68194A (es)
IE (1) IE64024B1 (es)
MX (1) MX173433B (es)
NZ (1) NZ233102A (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994041A (en) * 1985-04-06 1999-11-30 Eastman Kodak Company Process for buffering concentrated aqueous slurries
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
EP0663818A4 (en) * 1992-09-03 1996-04-24 Ibah Inc TASTE-COVERING PHARMACEUTICAL SUMMARY AND METHOD FOR PRODUCING THE SAME.
EP0620001A1 (en) * 1993-04-16 1994-10-19 McNEIL-PPC, INC. Aqueous pharmaceutical suspension and process for preparation thereof
DE4327147C2 (de) * 1993-08-12 1996-12-19 Klinge Co Chem Pharm Fab Arzneimittelzusammensetzung, welche neben dem Wirkstoff ein Gemisch aus Gelatine unterschiedlicher Löslichkeit enthält
FR2713931B1 (fr) * 1993-12-20 1996-04-05 Laurence Paris Nouvelles compositions pharmaceutiques liquides à base d'ibuprofène et leur procédé de préparation.
US5609998A (en) * 1994-12-29 1997-03-11 Eastman Kodak Company Process for dispersing concentrated aqueous slurries
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
WO1997041832A1 (fr) * 1996-05-02 1997-11-13 Taisho Pharmaceutical Co., Ltd. Suspension de medicament acide difficilement soluble dans l'eau
GB9625589D0 (en) 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
CA2330485C (en) * 1998-04-29 2008-07-08 Sumitomo Pharmaceuticals Co., Ltd. Oral formulation comprising biguanide and an organic acid
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
ES2323264T3 (es) * 2001-08-01 2009-07-10 Novartis Ag Composicion para enmascaramiento del sabor.
US20040132823A1 (en) * 2001-11-02 2004-07-08 Leo Pavliv Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
ES2197781B1 (es) * 2001-12-04 2005-02-16 Farmalider, S.A. Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.
JP4619658B2 (ja) * 2002-03-12 2011-01-26 富山化学工業株式会社 快い味の経口懸濁液および方法
US7300670B2 (en) 2002-04-03 2007-11-27 Unilab Pharmatech, Ltd. Oral suspension formulation
CN1655762B (zh) * 2002-06-17 2010-05-26 塔罗制药美国公司 布洛芬混悬剂
KR100509432B1 (ko) * 2002-12-13 2005-08-22 주식회사 동구제약 Ｓ(+)-이부프로펜을 함유한 시럽제 조성물 및 그의 제조방법
FR2850275B1 (fr) 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
EP1589944B1 (de) * 2003-02-06 2011-11-23 Gebro Pharma GmbH Pharmazeutische zubereitungen und verfahren zu deren herstellung
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
EP1674088A4 (en) * 2003-10-17 2009-04-15 Medrx Co Ltd Grape-based preparation containing a biguaneid drug
US20050095300A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
GB2407497A (en) * 2003-10-30 2005-05-04 John Anthony Walters Method and formulation for the rapid and stable taste-masking of insoluble pharmaceutically active compounds using a surfactant and a hydrocolloid
US20050266031A1 (en) 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
DK2377557T3 (en) * 2004-11-24 2017-02-06 Meda Pharmaceuticals Inc Compositions comprising azelastine and methods for its use
RU2009123445A (ru) 2006-11-21 2010-12-27 МакНЕЙЛ-ППС, ИНК. (US) Анальгетические суспензии модифицированного высвобождения
US9833510B2 (en) * 2007-06-12 2017-12-05 Johnson & Johnson Consumer Inc. Modified release solid or semi-solid dosage forms
US8362083B2 (en) * 2008-01-15 2013-01-29 C.B. Fleet Company Inc. Taste-masked docusate compositions
GB201006218D0 (en) 2010-04-14 2010-06-02 Ayanda As Composition
US9452135B2 (en) 2012-03-20 2016-09-27 Particle Dynamics International, Llc Gelling agent-based dosage form

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145440A (en) * 1977-08-18 1979-03-20 The Upjohn Company Liquid suspension of an aluminum salt of ibuprofen
US4361580A (en) * 1980-06-20 1982-11-30 The Upjohn Manufacturing Company Aluminum ibuprofen pharmaceutical suspensions
US4631580A (en) * 1984-11-09 1986-12-23 John Taube Video-stereoscopic-image-producing system
GB8609566D0 (en) * 1986-04-18 1986-05-21 Boots Co Plc Analgesic method
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions

Also Published As

Publication number Publication date
DE69006068D1 (de) 1994-03-03
KR900013952A (ko) 1990-10-22
IE901119L (en) 1990-09-28
IE64024B1 (en) 1995-06-28
MX173433B (es) 1994-03-03
KR0143899B1 (ko) 1998-07-15
CA1336819C (en) 1995-08-29
EP0390369A3 (en) 1991-05-15
ATE100313T1 (de) 1994-02-15
DE69006068T2 (de) 1994-05-11
ES2048428T3 (es) 1994-03-16
JP2847134B2 (ja) 1999-01-13
US4975465A (en) 1990-12-04
AU5226990A (en) 1990-10-04
HK68194A (en) 1994-07-22
JPH02286615A (ja) 1990-11-26
AU629622B2 (en) 1992-10-08
EP0390369B1 (en) 1994-01-19
DK0390369T3 (da) 1994-04-11
NZ233102A (en) 1991-08-27
AR245366A1 (es) 1994-01-31
EP0390369A2 (en) 1990-10-03

Similar Documents

Publication Publication Date Title
MX20055A (es) Procedimiento para la preparacion de una composicion acuosa de ibuprofen y procedimiento para su preparacion.
MX23672A (es) Derivados de glicopeptidos y procedimiento para su preparacion.
MX20476A (es) Composiciones de polipropileno y procedimiento para su preparacion.
MX10621A (es) Compuestos de piperazinil heterociclicos y procedimiento para su preparacion.
MX15701A (es) Composiciones de macrolidas y procedimiento para su preparacion.
MX9202290A (es) Nuevos derivados de tiopiranopirrol y procedimiento para su preparacion.
MX14910A (es) 2',3' -dideoxi-2',2'-difluoronucleosidos y procedimiento para su preparacion.
MX16687A (es) Compuestos de biarilo y procedimiento para su preparacion.
MX22255A (es) Compuestos de piridinil-quinolona y procedimiento para su preparacion.
MX21243A (es) Indenoindoles y procedimiento para su preparacion.
ES551635A0 (es) Procedimiento para la obtencion de una composicion farmaceutica de liberacion retardada a base de 9,10-dihidro-alcaloides.
IT8821300A0 (it) Procedimento di preparazione di morniflumato e analoghi.
MX17041A (es) Procedimiento para la preparacion de benzopirano pirazoles.
MX21871A (es) Procedimiento para la preparacion de oxadiazolil fenoxialquilisoxazoles y compuestos resultantes
IT9067657A0 (it) Procedimento per la preparazione di alfa-alchil-lattoni.
MX15050A (es) Procedimiento para la preparacion de derivados de 1-arilsulfinil-2-pirrolidinona.
MX15927A (es) Colorantes de formazano y procedimiento para su preparacion.
MX21657A (es) Nuevos agonistas de la dopamina y procedimiento para su preparacion
MX15982A (es) Compuestos hidrosolubles de ftalocianina y procedimiento para su preparacion.
MX23833A (es) Derivados de tiazolil-5-carbonamida y procedimiento para su preparacion.
ES513344A0 (es) "procedimiento para la preparacion de acidos heteroarilbenzoxepinalcanoicos y acidos 6,11-dihidro-11-oxodibenz b,e oxepinalcanoicos".
MX19566A (es) Nuevos derivados de 1-arilsulfonil-pirrolidin-2-tiona o de 1-arilsulfonil-piperidin-2-tiona y procedimiento para su preparacion
IT9067138A1 (it) Procedimento per la preparazione di alfa-alchil lattoni.
MX11486A (es) Procedimiento para la preparacion de una composicion farmaceutica y composicion obtenida.
MX21548A (es) Nuevas tienodiazepinas y procedimiento para su preparacion.